CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo

Lei Xu, Huan Yang, Yang Gao, Zeyu Chen, Liangfu Xie, Yulin Liu, Ying Liu, Xiaobao Wang, Hanwei Li, Weifeng Lai, Yuan He, Anzhi Yao, Liying Ma, Yiming Shao, Bin Zhang, Chengyan Wang, Chen Hu, Hongkui Deng

View at source ↗PDF ↗Article246 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1016/j.ymthe.2017.04.027
Published
May 17, 2017
Venue
Molecular Therapy
DOI
10.1016/j.ymthe.2017.04.027
PubMed
28527722
Categories
CRISPR and Genetic Engineering
License
cc-by-nc-nd
Provenance
openalex

Topics